Medication info

Zardiempa Tablet 25 mg (Empagliflozin)

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Empagliflozin›25mg / 1 tablet
Manufacturer / importer
Daewoong Bio Co., Ltd.
Appearance
Pale yellow, double convex, oval film-coated tablet
Packaging
10 tablets/box (10 tablets/PTP x 1), 30 tablets/box (10 tablets/PTP x 3), 30 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 202102092 · Approved 2021.03.05

This product's status changed to Approval withdrawn on 2025.04.14. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in adults with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
The recommended dose of this medicine is 10 mg once daily, both as monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, section 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations •Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well and whose glomerular filtration rate remains below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to below 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. This medicine should not be used in patients with end-stage renal disease (ESRD) or patients on dialysis, as efficacy is not expected. •Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment because it has not been studied in this population. •Older adults No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiating treatment with this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions for Use, section 4. General Precautions).

Ingredients

Manufacturer
Daewoong Bio Co., Ltd.

Efficacy & effects

Improvement of glycemic control in adults with type 2 diabetes mellitus

  • Type 2 diabetes
  • difficulty in blood sugar control
  • cardiovascular disease
  • risk of cardiovascular events
View approved original text

This medication is used to help control blood sugar levels in adults with type 2 diabetes in conjunction with dietary and exercise therapy. It can be used as monotherapy and can be combined with metformin or other diabetes medications as needed. It is particularly added for patients who struggle with blood sugar control on monotherapy with metformin alone or when blood sugar levels are not adequately controlled despite insulin and various combination therapies. Caution is advised in patients with type 2 diabetes who have cardiovascular disease, so please refer to a professional's guidance when administering this medication. This drug improves blood sugar control and is used in the treatment of type 2 diabetes.

How to take

Adult dose

The recommended dose of this medicine is 10 mg once daily, both as monotherapy and as add-on combination therapy with other glucose-lowering agents, such as insulin. If 10 mg of this medicine is well tolerated but additional glycemic control is needed, the dose may be increased to 25 mg once daily. When this medicine is administered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, section 3. Adverse Reactions). This medicine may be taken with or without food. Swallow the tablet whole. If you miss a dose, take it as soon as you remember. Do not take a double dose in one day. Special populations •Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Treatment with this medicine should not be initiated in patients with an estimated glomerular filtration rate (eGFR) below 60 ml/min/1.73m2 [or CrCl < 60 ml/min]. In patients who tolerate this medicine well and whose glomerular filtration rate remains below 60ml/min/1.73m2 [or CrCl < 60 ml/min], the dose should be adjusted to or maintained at 10 mg once daily. Discontinue this medicine if the glomerular filtration rate decreases to below 45 ml/min/1.73m2 [or CrCl < 45 ml/min]. This medicine should not be used in patients with end-stage renal disease (ESRD) or patients on dialysis, as efficacy is not expected. •Patients with hepatic impairment No dose adjustment is necessary for patients with mild or moderate hepatic impairment. Use of this medicine is not recommended in patients with severe hepatic impairment because it has not been studied in this population. •Older adults No dose adjustment is necessary based on age. Renal function and the risk of volume depletion should be considered in patients aged 75 years or older. Initiating treatment with this medicine is not recommended in patients aged 85 years or older because clinical experience is limited (see Precautions for Use, section 4. General Precautions).

Precautions

This medication should not be used in patients with known allergies to specific components. It may be dangerous when administered to patients with type 1 diabetes or diabetic ketoacidosis. It is not suitable for patients with severely impaired renal function or those undergoing dialysis. Patients with genetic metabolic disorders such as lactose intolerance or galactose intolerance should also not use this medication. For patients with slightly impaired renal function, dose adjustment is necessary, and it should be discontinued in cases of severe renal impairment. For patients with severe heart failure, the use of this medication is not recommended. Caution should be exercised if taken together with insulin or sulfonylureas due to the risk of hypoglycemia. This medication may cause side effects such as hypoglycemia, genital infections, urinary tract infections, increased urination, dehydration, and low blood pressure. Older patients are at increased risk of side effects due to fluid loss and should be monitored closely. A severe metabolic disturbance known as ketoacidosis may occur, so immediate consultation with healthcare professionals is needed if symptoms appear. Cases of liver damage have been reported, so patients with liver dysfunction should be cautious. This medication should be used cautiously in patients at risk of dehydration or low blood pressure, and fluid status should be monitored regularly. There is a risk of serious urinary tract infections such as urosepsis and pyelonephritis, so infection symptoms should be monitored carefully. There is an increased risk of genital fungal infections; treatment is needed if associated symptoms occur. Glucose may be detected in urine tests, so this should be considered when interpreting test results. Caution is also needed during driving or operating machinery due to the risk of hypoglycemia. There have been reports of increased risk of limb amputation, so care should be taken for foot health. A rare but serious infection called Fournier's gangrene may occur; treatment should be sought immediately if symptoms such as pain or swelling arise. This medication has minimal drug interactions, but caution is needed when used with insulin or diuretics. It is recommended not to use this medication during pregnancy and to avoid administration during breastfeeding. Safety has not been established in children under 18 years of age. No specific toxic symptoms have been reported in cases of overdose, but appropriate treatment is necessary based on clinical conditions. This medication should be kept out of reach of children, and transferring to other containers should be avoided.

Side effects

  • Hypoglycemia
  • vulvar vaginitis
  • balanitis
  • other genital infections
  • urinary tract infection
  • perineal gangrene
  • ketoacidosis
  • itching
  • rash
  • urticaria
Show 133 more
  • angioedema
  • decreased fluid volume
  • increased urination
  • dysuria
  • interstitial nephritis
  • thirst
  • elevated serum lipids
  • increased serum creatinine
  • decreased glomerular filtration rate
  • increased hematocrit
  • urosepsis
  • pyelonephritis
  • diarrhea
  • nausea
  • gastric ulcer
  • colitis
  • vomiting
  • ischemic colitis
  • gastrointestinal bleeding
  • soft tissue infection
  • appendiceal abscess
  • appendicitis
  • meningitis
  • chronic otitis media
  • peritonsillar abscess
  • pneumonia
  • pulmonary tuberculosis
  • sepsis
  • subcutaneous abscess
  • tubo-ovarian abscess
  • vestibular neuritis
  • headache
  • cerebral infarction
  • intracranial aneurysm
  • fever
  • vascular stent stenosis
  • vascular stent thrombosis
  • ureteral calculi
  • acute kidney injury
  • cervical inflammation
  • hyperglycemia
  • hyponatremia
  • diabetic foot
  • lumbago
  • glaucoma
  • pathological myopia
  • retinal detachment
  • retinal vein occlusion
  • rhegmatogenous retinal detachment
  • limb injury
  • road traffic accident
  • splenic injury
  • sternum fracture
  • angina
  • Prinzmetal angina
  • coronary artery disease
  • deep vein thrombosis
  • anxiety
  • acute cholecystitis
  • autoimmune hepatitis
  • cholelithiasis
  • otalgia
  • postural dizziness
  • anemia
  • lymphadenopathy
  • hypothyroidism
  • thyroid nodule
  • constipation
  • dyspepsia
  • upper respiratory infection
  • herpes zoster
  • dizziness
  • chest discomfort
  • chest pain
  • weakness
  • weight loss
  • vulvar pruritus
  • genital pruritus
  • dyslipidemia
  • vitamin D deficiency
  • dermoid cyst
  • seborrheic dermatitis
  • atopic dermatitis
  • nummular eczema
  • heat rash
  • sebaceous gland hyperplasia
  • lumbar spinal stenosis
  • myalgia
  • limb pain
  • musculoskeletal chest pain
  • arthralgia
  • cervical stenosis
  • fibromyalgia
  • flank pain
  • fracture pain
  • muscle weakness
  • musculoskeletal pain
  • osteoarthritis
  • osteoporosis
  • rotator cuff syndrome
  • astigmatism
  • cataract
  • allergic conjunctivitis
  • blurred vision
  • corneal erosion
  • macular fibrosis
  • eye discomfort
  • conjunctival congestion
  • eyelid swelling
  • visual impairment
  • vitreous floaters
  • vitreous hemorrhage
  • epistaxis
  • asthma
  • exertional dyspnea
  • productive cough
  • allergic rhinitis
  • retained phlegm
  • skin laceration
  • contusion
  • rib fracture
  • concussion
  • corneal abrasion
  • falls
  • hand fracture
  • ligamentous injury
  • open globe injury
  • pelvic fracture
  • palpitations
  • arteriosclerosis
  • diabetic vascular complications
  • peripheral artery occlusive disease
  • insomnia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from air or moisture. The recommended storage temperature is between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow, double convex, oval film-coated tablet

Package unit

10 tablets/box (10 tablets/PTP x 1), 30 tablets/box (10 tablets/PTP x 3), 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.